全文获取类型
收费全文 | 761篇 |
免费 | 69篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 6篇 |
妇产科学 | 9篇 |
基础医学 | 323篇 |
口腔科学 | 13篇 |
临床医学 | 42篇 |
内科学 | 239篇 |
皮肤病学 | 4篇 |
神经病学 | 15篇 |
外科学 | 17篇 |
综合类 | 43篇 |
预防医学 | 85篇 |
眼科学 | 4篇 |
药学 | 10篇 |
中国医学 | 1篇 |
肿瘤学 | 40篇 |
出版年
2023年 | 5篇 |
2022年 | 12篇 |
2021年 | 21篇 |
2020年 | 14篇 |
2019年 | 29篇 |
2018年 | 26篇 |
2017年 | 25篇 |
2016年 | 32篇 |
2015年 | 28篇 |
2014年 | 40篇 |
2013年 | 49篇 |
2012年 | 43篇 |
2011年 | 57篇 |
2010年 | 29篇 |
2009年 | 44篇 |
2008年 | 50篇 |
2007年 | 40篇 |
2006年 | 48篇 |
2005年 | 42篇 |
2004年 | 27篇 |
2003年 | 37篇 |
2002年 | 24篇 |
2001年 | 24篇 |
2000年 | 15篇 |
1999年 | 13篇 |
1998年 | 18篇 |
1997年 | 24篇 |
1996年 | 9篇 |
1995年 | 12篇 |
1994年 | 7篇 |
1993年 | 1篇 |
1992年 | 3篇 |
1991年 | 2篇 |
1986年 | 1篇 |
1980年 | 1篇 |
1978年 | 1篇 |
1976年 | 1篇 |
排序方式: 共有854条查询结果,搜索用时 31 毫秒
81.
Therapeutic implications of hepatitis B virus genotypes. 总被引:9,自引:0,他引:9
BACKGROUND/AIMS: Hepatitis B virus (HBV) is a global health problem. In addition to the implementation of universal hepatitis B vaccination, effective and individualized treatment of chronic hepatitis B to prevent progression into end-stage liver diseases and hepatocellular carcinoma is still needed. HBV has been designated eight genotypes (A-H) based on genome sequence divergence. The epidemiology of HBV genotypes and their implications on the responses to antiviral therapy have become increasingly recognized in both Asian and Western countries. METHODS: Published data are thus reviewed. Results: Each genotype has its distinct geographical and ethnic distribution. Genotypes A and D occur frequently in Africa, Europe, and India, while genotypes B and C are prevalent in Asia. Genotype E is restricted to West Africa, and genotype F is found in Central and South America. The distribution of genotypes G and H is less clear. Accumulating evidence indicates a better sustained response to conventional interferon in patients with genotype B than those with C, and in patients with genotype A than those with D. In contrast, conflicting results exist regarding the response to pegylated interferon. On the other hand, the therapeutic responses to nucleoside/nucleotide analogues are comparable among patients with different HBV genotypes. The impact of HBV subgenotypes, mixed genotype infections, and recombinants of different genotypes on the response to antiviral treatments awaits further examinations. CONCLUSION: Remarkable clinical and pathogenic differences do exist among HBV genotypes; however, researches on molecular and virologic mechanisms underlying the clinical phenotypes of different HBV genotypes are urgently needed. 相似文献
82.
Tallo T Norder H Tefanova V Krispin T Schmidt J Ilmoja M Orgulas K Pruunsild K Priimägi L Magnius LO 《Journal of medical virology》2007,79(4):374-382
During the last decade, there has been a dramatic increase in intravenous drug use in young adults in Estonia with an increased incidence of both hepatitis B and C as a consequence. Since genetic data are limited regarding hepatitis C virus (HCV) strains in Estonia, the aim of the study was to characterize HCV strains in different risk groups to determine their relatedness to strains from other geographical regions. Three hundred fifty-three anti-HCV positive sera collected during 1994-2004 from hospitalized patients, blood donors and health care workers were used as source of HCV RNA. Two hundred nine (59%) of the sera were positive for HCV RNA by PCR directed to the 5'-UTR region. For 174 strains the HCV subtype was determined by analyses of the NS5B and/or the 5'UTR-core regions. 1b (71%) was the most common subtype followed by 3a (24%), 2c (2%), 1a (1%), and 2a (1%). The 1b and 3a strains were similar to strains from other regions of the former USSR. Within genotype 1b there were several HCV lineages. However, for 3a there seemed to be two separate introductions into Estonia. There was a relative shift from subtype 1b to 3a in 1999-2000 with a further replacement of 3a with 1b in intravenous drug users in 2001 and onwards (P < 0.05). However, both subtypes were found to co-circulate in the community independent of risk factors. One patient was infected with the 2k/1b recombinant presumed to originate from St. Petersburg being the first isolate of this recombinant recovered outside Russia. 相似文献
83.
Yamamoto AY Mussi-Pinhata MM de Deus Wagatsuma VM Marin LJ Duarte G Figueiredo LT 《Journal of medical virology》2007,79(8):1164-1168
A case-control study design was used in order to compare the distribution of human cytomegalovirus (HCMV) glycoprotein B (gB) genotypes in 48 mothers of 49 congenitally infected infants with that observed in 144 mothers of 146 uninfected infants to study genetic variation of HCMV strains and maternal-fetal transmission. Congenital infection with HCMV was characterized by DNA detection and virus isolation from two urine or saliva samples collected prior to the third week of life. Genotyping of HCMV was carried out by a polymerase chain reaction-restriction fragment length polymorphism analysis of the variable region of the gB gene, testing for four genotypes. Genotype frequency was similar among the 28 non-transmitting mothers who were shedding virus (gB1: 25%; gB2: 28.6%; gB3: 42.8%; gB4: 0%), the 37 transmitting mothers (gB1: 21.6%; gB2: 46%; gB3: 27%; gB4: 0%), and the 49 infected infants (gB1: 39%; gB2: 37%; gB3: 24%; gB4: 0%). The same genotype was detected at different body sites (urine, saliva, and blood) of each infected newborn and in the respective mother (breast milk, urine, and saliva). Co-infection with multiple genotypes was observed in the immediate postpartum period in two mothers of infected infants (5.4%) and one non-transmitting mother (3.6%). The gB genotype was not correlated with intrauterine HCMV transmission. The genotype distribution found reflects the overall frequency of wild strains circulating in this geographic region. A single genotype is responsible for congenital HCMV infection. Co-infection with more than one strain, as characterized by gB genotype, was infrequent in women who were presumably immunocompetent. 相似文献
84.
Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women 总被引:1,自引:0,他引:1
Blossom DB Beigi RH Farrell JJ Mackay W Qadadri B Brown DR Rwambuya S Walker CJ Kambugu FS Abdul-Karim FW Whalen CC Salata RA 《Journal of medical virology》2007,79(6):758-765
Human papillomavirus (HPV) infection is associated with almost all cases of cervical cancer, and cervical cancer is a common malignancy in women living in developing countries. A cross-sectional study was conducted to determine the prevalence of HPV infection, human immunodeficiency virus (HIV) infection, and cervical cytologic abnormalities in women presenting to a sexually transmitted infections clinic in Kampala, Uganda. In June and July, 2002, 135 women underwent complete physical exams including Papanicolaou (Pap) smears. HIV status was evaluated by serology. Cervical and vaginal swabs were obtained by clinicians and tested for HPV genotypes by PCR/reverse blot strip assay. Of the 106 women with cervical swabs adequate for HPV testing, the HPV prevalence was 46.2% (49/106). HIV prevalence was 34.9% (37/106). High risk genotypes 52, 58, and 16 were the genotypes detected most commonly. Eighteen percent (9/49) of women infected with HPV were found to have genotypes 16 and/or 18. Seventy-three percent (27/37) of HIV-positive women versus 16% (10/63) of HIV-negative women had abnormal Pap smears (P < 0.0001). Among HIV-positive women, abnormal Pap smears were associated with the presence of high risk HPV genotypes (P < 0.001). The majority of women infected with HPV attending this sexually transmitted infections clinic in Uganda were infected with high risk HPV genotypes other than 16 and 18. Future studies should focus on whether current HPV vaccine formulations, that are limited to high risk genotypes 16 and 18, would be effective at decreasing the burden of cervical cancer in this population. 相似文献
85.
86.
Hepatitis C virus long‐term persistence in peripheral blood mononuclear cells in patients with haemophilia. Detection of occult genotype 1
下载免费PDF全文
![点击此处可从《Journal of viral hepatitis》网站下载免费的PDF全文](/ch/ext_images/free.gif)
C. Parodi G. García M. C. Monzani A. Culasso N. Aloisi M. Corti R. Campos M. M. de E de Bracco P. Baré 《Journal of viral hepatitis》2015,22(7):607-616
Peripheral blood mononuclear cells (PBMC) from chronic hepatitis C virus‐infected persons can harbour viral variants that are not detected in plasma samples. We explored the presence and persistence of HCV genotypes in plasma and PBMC cultures from 25 HCV‐monoinfected and 25 HIV/HCV‐coinfected patients with haemophilia. Cell cultures were performed at different time points between 1993 and 2010‐2011, and the HCV genome was examined in culture supernatants. Sequential plasma samples were studied during the same time period. Analysing sequential plasma samples, 21% of patients had mixed‐genotype infections, while 50% had mixed infections determined from PBMC culture supernatants. HIV coinfection was significantly associated with the presence of mixed infections (OR = 4.57, P = 0.02; 95% CI = 1.38–15.1). In our previous study, genotype 1 was found in 72% of 288 patients of this cohort. Similar results were obtained with the sequential plasma samples included in this study, 69% had genotype 1. However, when taking into account plasma samples and the results from PBMC supernatants, genotype 1 was identified in 94% of the population. The PBMC‐associated variants persisted for 10 years in some subjects, emphasizing their role as long‐term reservoirs. The presence of genotype 1 in PBMC may be associated with therapeutic failure and should not be disregarded when treating haemophilic patients who have been infected by contaminated factor concentrates. The clinical implications of persistent lymphotropic HCV variants deserve further examination among multiple exposed groups of HCV‐infected patients. 相似文献
87.
88.
89.
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study 总被引:1,自引:0,他引:1
Payan C Roudot-Thoraval F Marcellin P Bled N Duverlie G Fouchard-Hubert I Trimoulet P Couzigou P Cointe D Chaput C Henquell C Abergel A Pawlotsky JM Hezode C Coudé M Blanchi A Alain S Loustaud-Ratti V Chevallier P Trepo C Gerolami V Portal I Halfon P Bourlière M Bogard M Plouvier E Laffont C Agius G Silvain C Brodard V Thiefin G Buffet-Janvresse C Riachi G Grattard F Bourlet T Stoll-Keller F Doffoel M Izopet J Barange K Martinot-Peignoux M Branger M Rosenberg A Sogni P Chaix ML Pol S Thibault V 《Journal of viral hepatitis》2005,12(4):405-413
Summary. This cross-sectional study aimed to investigate, during a short period between 2000 and 2001, in a large population of patients with chronic hepatitis C, the epidemiological characteristics of hepatitis C virus (HCV) genotypes in France. Data from 26 referral centres, corresponding to 1769 patients with chronic hepatitis C were collected consecutively during a 6-month period. HCV genotyping in the 5'-non-coding region (NCR) was performed in each center using the line probe assay (LiPA, in 63% of cases), sequencing (25%) or primer-specific polymerase chain reaction (PCR) (12%). HCV genotypes 1a, 1b, 2, 3, 4, 5, non-subtyped 1 and mixed infection were found in 18, 27, 9, 21, 9, 3, 11 and 1% of our population, respectively. HCV genotype distribution was associated with gender, age, source and duration of infection, alanine aminotransferase (ALT) levels, cirrhosis, alcohol consumption, hepatitis B virus (HBV) and human immunodeficiency virus (HIV) coinfection. In multivariate analysis, only the source of infection was the independent factor significantly associated with genotype ( P = 0.0001). In conclusion, this study shows a changing pattern of HCV genotypes in France, with i.v. drug abuse as the major risk factor, an increase of genotype 4, and to a lesser extent 1a and 5, and a decrease of genotypes 1b and 2. The modification of the HCV genotype pattern in France in the next 10 years may require new therapeutic strategies, and further survey studies. 相似文献
90.
Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy 总被引:15,自引:0,他引:15
SUMMARY: Phylogenetic analysis has led to the classification of hepatitis B virus into eight genotypes, designated A to H. The genotypes have differences in biological properties and show heterogeneity in their global distribution. These attributes of the genotypes may account not only for differences in the prevalence of hepatitis B virus mutants in various geographic regions, but also be responsible for differences in the clinical outcome and response to antiviral treatment in different population groups. 相似文献